Researchers first recognized antimony-119 (Sb-119) more than two decades ago as a potentially promising radioactive isotope for targeted cancer therapy. However, the lack of binding molecules has limited its medical use.
Accelerating The Materials Transition
placeholder text
Copyright @ 2025 ALT LABS